Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 886371-22-8 | MDL No. : | MFCD02260845 |
Formula : | C8H3Cl2F3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HXPJKNUPFSLMBO-UHFFFAOYSA-N |
M.W : | 243.01 g/mol | Pubchem ID : | 24726839 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 46.85 |
TPSA : | 17.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.96 cm/s |
Log Po/w (iLOGP) : | 1.95 |
Log Po/w (XLOGP3) : | 3.98 |
Log Po/w (WLOGP) : | 5.0 |
Log Po/w (MLOGP) : | 3.37 |
Log Po/w (SILICOS-IT) : | 4.03 |
Consensus Log Po/w : | 3.67 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.04 |
Solubility : | 0.0222 mg/ml ; 0.0000914 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.04 |
Solubility : | 0.0222 mg/ml ; 0.0000913 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.47 |
Solubility : | 0.00822 mg/ml ; 0.0000338 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 1.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h; Stage #2: at 0℃; for 2.5 h; |
Example 1: l-(2,5-Dichloro-phenyl)-2,2,2-trifluoro-ethanone A solution of 1 ,4-dichlorobenzene (20 g, 136 mmol) in anhydrous THF (200 mL) was cooled to -78 °C. n-BuLi (150 mmol in 60 mL hexane) was added. The mixture was stirred for 1 h, followed by addition of methyl trifluoroacetate (18 mL, 179 mmol) in 30 min. The mixture was allowed to warm up to 0 °C and then stirred for 2 h. Pre-cooled saturated aqueous ammonium chloride solution (100 mL) was added. The phases were separated. The organic phase was concentrated under vacuum and the residue was dissolved in ethyl acetate (200 mL). The water phase was extracted with ethyl acetate (200 mL). The two ethyl acetate phases were combined and then washed with brine (200 mL). The phases were separated. The organic phase was dried over Na2S04 and then filtrated. The filtrate was concentrated under vacuum. The residue was purified via column chromatography using silica gel eluting with ethyl acetate / hexane (1/10 v/v) to afford after isolation and drying l-(2,5-Dichloro-phenyl)-2,2,2-trifluoro-ethanone as an orange oil (28.5 g, 86 percent yield).1H NMR (400 MHz, CDC13) delta 7.67 (s, 1H), 7.56 to 7.50 (m, 2H). |
86% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h; Stage #2: at -78 - 0℃; for 2.5 h; |
Example 1: l-(2,5-Dichloro-phenyl)-2,2,2-trifluoro-ethanoneA solution of 1 ,4-dichlorobenzene (20 g, 136 mmol) in anhydrous THF (200 mL) was cooled to -78 °C. n-BuLi (150 mmol in 60 mL hexane) was added. The mixture was stirred for 1 h, followed by addition of methyl trifluoroacetate (18 mL, 179 mmol) in 30 min. The mixture was allowed to warm up to 0 °C and then stirred for 2 h.Pre-cooled saturated aqueous ammonium chloride solution (100 mL) was added. The phases were separated. The organic phase was concentrated under vacuum and the residue was dissolved in ethyl acetate (200 mL). The water phase was extracted with ethyl acetate (200 mL). The two ethyl acetate phases were combined and then washed with brine (200 mL). The phases were separated. The organic phase was dried over Na2S04 and then filtrated. The filtrate was concentrated under vacuum. The residue was purified via column chromatography using silica gel eluting with ethyl acetate / hexane (1/10 v/v) to afford after isolation and dryingl-(2,5-Dichloro-phenyl)-2,2,2-trifluoro-ethanone as an orange oil (28.5 g, 86 percent yield).1H NMR (400 MHz, CDC13) delta 7.67 (s, 1H), 7.56 to 7.50 (m, 2H). |
86% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h; Stage #2: at 0℃; for 2.5 h; |
Example 1: l-(2,5-Dichloro-phenyl)-2,2,2-trifluoro-ethanoneA solution of 1 ,4-dichlorobenzene (20 g, 136 mmol) in anhydrous THF (200 mL) was cooled to -78 °C. n-BuLi (150 mmol in 60 mL hexane) was added. The mixture was stirred for 1 h, followed by addition of methyl trifluoroacetate (18 mL, 179 mmol) in 30 min. The mixture was allowed to warm up to 0 °C and then stirred for 2 h.Pre-cooled saturated aqueous ammonium chloride solution (100 mL) was added. The phases were separated. The organic phase was concentrated under vacuum and the residue was dissolved in ethyl acetate (200 mL). The water phase was extracted with ethyl acetate (200 mL). The two ethyl acetate phases were combined and then washed with brine (200 mL). The phases were separated. The organic phase was dried over Na2S04 and then filtrated. The filtrate was concentrated under vacuum. The residue was purified via column chromatography using silica gel eluting with ethyl acetate / hexane (1/10 v/v) to afford after isolation and dryingl-(2,5-Dichloro-phenyl)-2,2,2-trifluoro-ethanone as an orange oil (28.5 g, 86 percent yield).1H NMR (400 MHz, CDC13) delta 7.67 (s, 1H), 7.56 to 7.50 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77.3% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -75 - -70℃; for 1 h; Cooling with liquid nitrogen Stage #2: at -80 - -75℃; for 0.5 h; |
General procedure: To a chilled to –75 °C solution of 1,4-dichlorobenzene (10.0 g,68 mmol) in anhydrous THF (150 mL), BunLi (30 mL, 75 mmol,2.5 M solution in hexane) was added dropwise maintaining the reaction temperature below –70 °C. The reaction mixture wasstirred at –75 °C for 1 h, cooled to –80 °C with liquid nitrogenand then a solution of ethyl trifluoroacetate (10.8 g, 76 mmol) in THF (15 mL) was slowly added maintaining the reaction temperature below –75 °C. After 30 min stirring at –75 °C, thereaction mixture was warmed up to –50 °C, and 10percent HCl (20 mL) was added following by warming up to 0 °C and additionof another portion of 10percent HCl (10 mL) until distinct acidity ofthe aqueous layer was achieved. The organic layer was separated and the aqueous layer was extracted with diethyl ether (2×40 mL). The combined organics were washed with brine (2×50 mL), dried with Na2SO, and the drying agent was filtered off. The solvents were distilled off under normal pressure using the Vigreux distillation column. Vacuum distillation of the residue afforded 12.8 g (77.3percent) of compound 2b as light yellow liquid. B.p. 92—100 °C (10 Torr), nD20 1.4921. |
[ 92736-81-7 ]
1-(2,4-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.98
[ 321-37-9 ]
1-(4-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 321-31-3 ]
1-(3-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 130336-16-2 ]
1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.88
[ 129322-81-2 ]
1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone
Similarity: 0.85
[ 92736-81-7 ]
1-(2,4-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.98
[ 321-37-9 ]
1-(4-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 321-31-3 ]
1-(3-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 130336-16-2 ]
1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.88
[ 129322-81-2 ]
1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone
Similarity: 0.85
[ 92736-81-7 ]
1-(2,4-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.98
[ 321-37-9 ]
1-(4-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 321-31-3 ]
1-(3-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 130336-16-2 ]
1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.88
[ 129322-81-2 ]
1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone
Similarity: 0.85
[ 92736-81-7 ]
1-(2,4-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.98
[ 321-37-9 ]
1-(4-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 321-31-3 ]
1-(3-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 130336-16-2 ]
1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.88
[ 129322-81-2 ]
1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone
Similarity: 0.85
[ 92736-81-7 ]
1-(2,4-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.98
[ 321-37-9 ]
1-(4-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 321-31-3 ]
1-(3-Chlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.91
[ 130336-16-2 ]
1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone
Similarity: 0.88
[ 129322-81-2 ]
1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone
Similarity: 0.85